ABVC BioPharma, Inc. (ABVC) vs BRIACELL THERAP (BCTX)
ABVC BioPharma, Inc. and BRIACELL THERAP are both Biotechnology companies. ABVC BioPharma, Inc. and BRIACELL THERAP are of similar size ($37.2M and $34.0M). ABVC BioPharma, Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.9×. Across the 10 metrics below, ABVC BioPharma, Inc. leads on 7 and BRIACELL THERAP on 3.
Valuation
Profitability
| Metric | ABVC | BCTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (65.32%) | (173.55%) | (57.72%) |
| Return on assets | (39.88%) | (139.20%) | (49.22%) |
| Return on invested capital | (33.45%) | (3,311.00%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack